Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Green Fresh Biotechnology Co's EBIT per Share for the
six
months ended in Jun. 2026 was HK$0.01.
Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2026 was HK$0.06.
During the past 12 months, the average EBIT per Share Growth Rate of Green Fresh Biotechnology Co was -13.20% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -50.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Green Fresh Biotechnology Co's EBIT per Share or its related term are showing as below:
HKSE:01084'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -50.3 Med: -2.1 Max: 30.2
Current: -50.3
During the past 10 years, the highest 3-Year average EBIT per Share Growth Rate of Green Fresh Biotechnology Co was 30.20% per year. The lowest was -50.30% per year. And the median was -2.10% per year.
HKSE:01084's 3-Year EBIT Growth Rate is ranked worse than 95.59% of 1587
companies
in the Consumer Packaged Goods industry
Industry Median: 7.1
vs HKSE:01084: -50.30
Green Fresh Biotechnology Co (HKSE:01084) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Green Fresh Biotechnology Co EBIT per Share Related Terms
Green Fresh Biotechnology Co EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.06
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Green Fresh Biotechnology Co (HKSE:01084) has a EBIT per Share of HK$0.06 as of Jun. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Green Fresh Biotechnology Co and its competitors. According to the industry distribution chart, Green Fresh Biotechnology Co ranks #1517 out of 1587 companies in the Consumer Packaged Goods industry, placing it in the top 95.6%.
Is Green Fresh Biotechnology Co's EBIT per Share too high?
Green Fresh Biotechnology Co's current EBIT per Share is HK$0.06. Based on the distribution chart, Green Fresh Biotechnology Co ranks #1517 out of 1587 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Green Fresh Biotechnology Co has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Green Fresh Biotechnology Co's EBIT per Share compare to ADM and BG?
According to the Consumer Packaged Goods industry distribution chart, Green Fresh Biotechnology Co ranks #1517 out of 1587 companies for EBIT per Share. This places Green Fresh Biotechnology Co in the lower half of its industry. The industry median EBIT per Share is 7.10. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Consumer Packaged Goods company?
The median EBIT per Share among Consumer Packaged Goods companies is 7.10, based on 1,587 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Green Fresh Biotechnology Co and its competitors. For the Consumer Packaged Goods industry, the median EBIT per Share is 7.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Green Fresh Biotechnology Co's current EBIT per Share is HK$0.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Green Fresh Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Green Fresh Biotechnology Co (HKSE:01084) is currently considered Fairly Valued. The stock's GF Value™ is HK$0.70, compared to a current price of HK$0.68 — trading 3.6% below its estimated fair value. The current EBIT per Share is HK$0.06. Green Fresh Biotechnology Co's overall GF Score™ is 58/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Green Fresh Biotechnology Co (HKSE:01084), the current EBIT per Share is HK$0.06 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Green Fresh Biotechnology Co (HKSE:01084) Overvalued in 2026?
Based on GuruFocus' analysis, Green Fresh Biotechnology Co stock appears to be undervalued.
The current stock price of HK$0.68 is trading 3.6% below its estimated GF Value™ of HK$0.70.
GuruFocus considers Green Fresh Biotechnology Co to be Fairly Valued.
Key valuation signals for HKSE:01084:
EBIT per Share: HK$0.06
GF Value™: HK$0.70 vs. price of HK$0.68 (3.6% below fair value)
No single metric tells the full story. See the HKSE:01084 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Green Fresh Biotechnology Co Ltd, formerly Green Future Food Hydrocolloid Marine Science Co Ltd is engaged in manufacturing and sales of food manufacturing hydrocolloid products including carrageenan products, agar-agar products, blended products, and konjac products in the People's Republic of China and overseas. Its segments include Manufacturing and sales of agar-agar products, which derives maximum revenue; Manufacturing and sales of carrageenan; Manufacturing and sales of konjac products; Manufacturing and sales of blended products; and Others, such as trading of seaweed powder and other operations. Its operations are spread across Chinese Mainland, which derives maximum revenue; Europe; Asia (excluding Chinese Mainland); South America; North America; Africa; and Oceania.
58GF Score
Get the complete analysis for HKSE:01084
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01084 has been successfully added to your 
